echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Mov Disord: Is it possible to suffer from Parkinson's, check glutathione and take a look

    Mov Disord: Is it possible to suffer from Parkinson's, check glutathione and take a look

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The reduction of glutathione (GSH) is considered to be one of the earliest biochemical changes in Parkinson's disease
    .


    Autopsy studies have shown that GSH is lacking in the substantia nigra (SN) of patients with Parkinson's disease or incidental Lewy body disease (ILBD), and there is substantial evidence to support GSH interference in the clinical stage of PD


    Nikolaos Scarmeas et al .
    explored the potential role of plasma glutathione as a precursor PD (pPD) risk/susceptibility biomarker by detecting the longitudinal correlation between plasma glutathione (GSH) and the probability trajectory of pPD
    .

    Nikolaos Scarmeas et al .
    explored the potential role of plasma glutathione as a precursor PD (pPD) risk/susceptibility biomarker by detecting the longitudinal correlation between plasma glutathione (GSH) and the probability trajectory of pPD
    .


    The research team followed up a total of 405 community residents (median age [interquartile range] = 73.
    2 [7.
    41] years), the average follow-up time (standard deviation) was 3.
    0 (0.
    9) years, no Parkinson's disease clinical Features
    .

    For every increase of 1 μmol/L in plasma GSH, the incidence of pPD decreased by 0.
    4% during the 1-year follow-up (95% confidence interval [CI], 0.
    1%-0.
    7%; P = 0.
    017)
    .

    For every increase of 1 μmol/L in plasma GSH, the incidence of pPD decreased by 0.
    4% during the 1-year follow-up (95% confidence interval [CI], 0.
    1%-0.
    7%; P = 0.
    017)
    .


    Compared with the participants with the lowest glutathione levels, the participants in the top tertile of glutathione had a 12.
    9% slower increase in the probability of pPD during the 1-year follow-up
    .

    Compared with the participants with the lowest glutathione levels, the participants in the top tertile of glutathione had a 12.
    9% slower increase in the probability of pPD during the 1-year follow-up
    .


    In summary, the plasma glutathione concentration is related to the pPD probability trajectory, and a lower concentration predicts that pPD may increase
    .


    Current research results indicate that plasma glutathione may help identify individuals who may reach the diagnostic threshold of pPD more quickly


    In summary, the plasma glutathione concentration is related to the pPD probability trajectory, and a lower concentration predicts that pPD may increase


    Plasma Glutathione and Prodromal Parkinson's Disease Probability [published online ahead of print, 2021 Oct 25].


    Plasma Glutathione and Prodromal Parkinson's Disease Probability [published online ahead of print, 2021 Oct 25].
    Mov Disord.
    2021;10.
    1002/mds.
    28826.
    doi:10.
    1002/mds.
    28826 Plasma Glutathione and Prodromal Parkinson's Disease Probability [published online ahead of print .
    , 2021 Oct 25] Mov Disord 2021; 10.
    1002 / mds.
    28826 doi:.
    .
    10.
    1002 / mds.
    28826 in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.